Market News / Story
Samantha Pearce to Retire as Jazz Pharmaceuticals' Chief Commercial Officer
·
Jazz Pharmaceuticals appointed Samantha Pearce, Executive Vice President, Chief Commercial Officer, who has notified the company she will retire upon appointment of her successor or by June 30, 2027. IndividualSamantha PearceRoleExecutive Vice President, Chief Commercial OfficerType of ChangeRetirement (notice)Effective DateUpon selection and appointment of successor or June 30, 2027ReasonRetirement (per notification)Replacement InfoCompany will commence formal search…